These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 6022771)

  • 21. Cutaneous and ocular changes associated with the use of chlorpromazine.
    Wolf ME; Richer S; Berk MA; Mosnaim AD
    Int J Clin Pharmacol Ther Toxicol; 1993 Aug; 31(8):365-7. PubMed ID: 8225679
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chlorpromazine and the eye of the dog. V. Attempt to produce lenticular lesions.
    Barron CN; Rubin LF; Steelman RL
    Exp Mol Pathol; 1972 Apr; 16(2):169-71. PubMed ID: 5062561
    [No Abstract]   [Full Text] [Related]  

  • 23. Ocular effects of phenothiazine derivatives and reversibility.
    Mathalone MB
    Dis Nerv Syst; 1968 Mar; 29(3):Suppl:29-35. PubMed ID: 5672561
    [No Abstract]   [Full Text] [Related]  

  • 24. [Ocular complications in long-term chlorpromazine treatment].
    Klíma M; Klímová A
    Cesk Oftalmol; 1977 Sep; 33(5):349-52. PubMed ID: 922908
    [No Abstract]   [Full Text] [Related]  

  • 25. [Conjunctival melanosis caused by epinephrine].
    Zolog N; Leibovici M
    Bull Mem Soc Fr Ophtalmol; 1973; 86(0):198-200. PubMed ID: 4794290
    [No Abstract]   [Full Text] [Related]  

  • 26. Ocular complications of chlorpromazine therapy.
    Petrohelos MA; Tricoulis D
    Ophthalmologica; 1969; 159(1):31-8. PubMed ID: 4984273
    [No Abstract]   [Full Text] [Related]  

  • 27. PIGMENT DEPOSITION IN VISCERA ASSOCIATED WITH PROLONGED CHLORPROMAZINE THERAPY.
    GREINER AC; NICOLSON GA
    Can Med Assoc J; 1964 Sep; 91(12):627-35. PubMed ID: 14201249
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Some iatrogenic ocular diseases from systemically administered drugs.
    Bernstein HN
    Int Ophthalmol Clin; 1970; 10(3):553-619. PubMed ID: 4933547
    [No Abstract]   [Full Text] [Related]  

  • 29. Ocular involvement in cutaneous porphyria. A clinical and histological report.
    Sevel D; Burger D
    Arch Ophthalmol; 1971 May; 85(5):580-5. PubMed ID: 5087600
    [No Abstract]   [Full Text] [Related]  

  • 30. Harmful side effects induced by a piperazine derivative in experimental animals. I. Ophthalmological observations.
    Mezey P; Köteles GJ; Takáts A; Jobbágyi P
    Acta Med Acad Sci Hung; 1970; 27(1):79-85. PubMed ID: 5454560
    [No Abstract]   [Full Text] [Related]  

  • 31. Congenital ocular melanosis, conjunctival naevus, conjunctival melanosis, conjunctival melanoma.
    Manschot WA
    Ophthalmologica; 1966; 152(6):495-505. PubMed ID: 5964841
    [No Abstract]   [Full Text] [Related]  

  • 32. Corneal and lens changes after prolonged treatment with chlorpromazine.
    Sandvig K
    Acta Ophthalmol (Copenh); 1965; 43(5):730-4. PubMed ID: 5898525
    [No Abstract]   [Full Text] [Related]  

  • 33. Ocular and cutaneous effects of chronic phenothiazine therapy.
    Bond WS; Yee GC
    Am J Hosp Pharm; 1980 Jan; 37(1):74-8. PubMed ID: 6102438
    [No Abstract]   [Full Text] [Related]  

  • 34. Chlorpromazine and the eye of the dog. IV. Reversibility of ocular lesions.
    Barron CN; Rubin LF; Steelman RL
    Exp Mol Pathol; 1972 Apr; 16(2):163-8. PubMed ID: 5062560
    [No Abstract]   [Full Text] [Related]  

  • 35. [Complications on the part of the eyes during employment of psychotropic drugs (review of the foreign literature)].
    Gol'dovskaia IL
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1969; 69(6):935-9. PubMed ID: 4905472
    [No Abstract]   [Full Text] [Related]  

  • 36. Premalignant melanosis of the conjunctiva and the cornea in xeroderma pigmentosum.
    Paridaens AD; McCartney AC; Hungerford JL
    Br J Ophthalmol; 1992 Feb; 76(2):120-2. PubMed ID: 1739708
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pigmentation after long-term topical use of adrenaline compounds.
    Mooney D
    Br J Ophthalmol; 1970 Dec; 54(12):823-6. PubMed ID: 5517425
    [No Abstract]   [Full Text] [Related]  

  • 38. [Benign congenital ocular melanosis].
    Stucchi CA; Kessous-Odermatt FL
    Ophthalmologica; 1970; 161(2):245-54. PubMed ID: 5457671
    [No Abstract]   [Full Text] [Related]  

  • 39. [Ultrastructural study of corneal thickening in the course of chlorpromazine treatment].
    Pouliquen Y; Graf B; Bisson J; Feuvrier YM; Delattre A
    Arch Ophtalmol Rev Gen Ophtalmol; 1970 Nov; 30(11):769-82. PubMed ID: 4250388
    [No Abstract]   [Full Text] [Related]  

  • 40. [Ocular changes in long-term treatment with Largactil].
    Kalberer M; Atar Z; Bider E
    Ophthalmologica; 1970; 161(2):118-24. PubMed ID: 4989755
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.